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Prior to the report by Lu et al., little 
attention was paid to the possibility of 
a post-UVR effect by these seemingly 
innocuous formulations. Their paper rais-
es the question of whether these agents 
belong on a list of more active com-
pounds analogous to tumor promoters (in 
two-stage carcinogenesis, in which UVR 
is the initiator; see Forbes et al., 1979; 
Sambuco and Forbes, 1983). Beyond the 
interest in Lu and colleagues’ challenging 
laboratory data is the obvious question 
of relevance to humans. Animal studies 
are critical to hazard identification but 
are still lacking as a risk-assessment tool 
(Forbes and Sambuco, 1988). More spe-
cifically, for such studies to provide guid-
ance on estimating the possible impact 
on humans, dose–response (“calibra-
tion”) treatment groups are needed with 
which to calculate “potency factors” 
(Forbes et al., 2003). When available, 
calibration treatment groups provide 
a dynamic range of responses to UVR 
alone, permitting accurate interpolation 
and reasonable extrapolation for data 
from the groups also receiving the test 
agents. If significant differences are found 
between treatment groups and the cor-
responding calibration group, then cal-
culating a scaling factor or potency ratio 
may provide a measure of the effective-
ness of each treatment, i.e., an estimated 
ratio of UVR doses to produce the same 
response (Forbes et al., 2003). Restated, 
deviations from a “zero-effect” level 
in tumor response can be expressed in 
terms of a potency factor (i.e., expressed 
as the mathematical equivalent of chang-
ing the UV dose by a specified fraction). 
One can only hope that such experimen-
tal data will become available from addi-
tional studies, particularly in view of the 
findings of Lu et al. (2009).
Clinical data that can be used to 
evaluate the possible relevance of Lu 
and colleagues’ findings to humans 
will not be easy to extract, although an 
analogous question about another type 
of interaction was answered recently by 
Karagas et al. (2007). They presented evi-
dence that the use of recognized photo-
sensitizing agents can increase skin can-
cer incidence in patients requiring these 
mediations (as compared with others in 
the general population). Their approach 
may suggest a methodology for use in 
the current context.
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Macrophage Inhibitory cytokine-1:  
A new Player  
in Melanoma Development
Toshiharu Yamashita1, Akihiro Yoneta1 and Tokimasa Hida1
Macrophage inhibitory cytokine-1 (MIc-1) is a divergent member of the TGf-β 
superfamily. Although it has been reported to exhibit both tumorigenic and 
antitumorigenic activities, Boyle et al. report in this issue that MIc-1 expression 
was correlated with the tumorigenicity of melanoma cells. The elucidation of 
signaling pathways around MIc-1 might contribute to prospective targeting 
therapy for melanoma.
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MIC-1, also called placental bone mor-
phogenetic protein, prostate-derived 
factor, growth differentiation factor 15, 
and nonsteroidal anti-inflammatory 
drug-activated gene, was independently 
cloned by four groups from cDNA 
libraries of monocytoid cell line U937, 
placenta, and spleen. Its predicted 
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amino acid sequences contain the sites 
and domains common to transforming 
growth factor-β (TGF-β) family mem-
bers, such as the N-terminal signal 
sequence, glycosylation site, proteolyt-
ic cleavage site, and seven C-terminal 
cysteine residues (Bootcov et al., 1997). 
After being translated to a full-length of 
308 amino acids (aa), MIC-1 is prote-
olytically processed from pro-MIC-1 
(279 aa) to mature protein (112 aa) 
and transported into Golgi fractions for 
secretion as a disulfide-linked homodi-
mer (Bauskin et al., 2000). A part of the 
pro-MIC-1 (279 aa) may be excreted 
from cells, bind to the local extracellu-
lar matrix, and be subsequently cleaved 
to a mature form as a source of locally 
bioactive MIC-1.
TGF-β/bone morphogenetic protein/
growth differentiation factor family pro-
teins are important regulators of cellu-
lar physiological processes, including 
cell survival, proliferation, differentia-
tion, migration, and apoptosis. Recent 
reports suggest that MIC-1 is related 
to p63-directed differentiation of epi-
dermal keratinocytes (Ichikawa et al., 
2008) and that it is a central regula-
tor of appetite in anorexia and weight 
loss associated with cancer (Johnen et 
al., 2007). Like TGF-β, MIC-1 has been 
shown to exhibit antitumorigenic and 
proapoptotic activities in vivo and in 
vitro. Several reports describe MIC-1 
as a mediator of p53-dependent or 
p53-independent growth arrest and 
apoptosis. The MIC-1 gene was identi-
fied as the most prominent transacti-
vation target of p53, and MIC-1 is the 
only known secretory p53 regulatory 
product. In glioblastoma cells, MIC-1 
is induced not only by p53 but also 
by anoxia, and, interestingly, MIC-1-
overexpressing glioblastoma cells lose 
their tumor-forming ability in nude 
mice, with their in vitro growth ability 
unaffected (Albertoni et al., 2002).
The phosphatidylinositol 3-kinase–
Akt pathway was reported to negative-
ly regulate MIC-1 expression in col-
orectal carcinoma cell line HCT-116 
through glycogen synthase kinase-3β 
(Yamaguchi et al., 2004). In spite of 
the experimental results showing that 
MIC-1, as well as TGF-β, suppresses 
growth or induces apoptosis of various 
types of cancer cells, increased MIC-1 
expression has been documented in a 
variety of epithelial cancer cell lines, 
including breast, pancreatic, colorec-
tal, prostate, and cervical cancers 
(Welsh et al., 2003). The serum MIC-1 
level is the best single predictor of the 
presence of pancreatic carcinoma and 
is correlated with the presence of pros-
tate cancer metastases.
Boyle et al. report in this issue 
that melanoma cell lines and meta-
static melanomas expressed larger 
amounts of MIC-1 than melanocytes, 
nevi, and primary lesions of mela-
noma. Knockdown of MIC-1 expres-
sion in three melanoma cell strains 
tested resulted in a significant decrease 
in tumorigenicity but did not affect 
anchorage-independent growth of the 
cells. The authors demonstrated that, in 
melanoma cells, expression of MIC-1 
was at least partially dependent on 
the mitogen-activated protein kinase 
(MAPK) pathway and that stem cell fac-
tor–mediated c-Kit activation enhanced 
the level of MIC-1. Because c-Kit trig-
gers MAPK-mediated phosphoryla-
tion of microphthalmia-associated 
transcription factor (MITF), Boyle and 
colleagues suggested that the MAPK–
extracellular signal-regulated kinase 
(ERK)–MITF-pathway was responsible 
for at least some, but not all, high-level 
expression of MIC-1. Also, by microar-
ray analysis, MIC-1 was identified as 
one of the genes upregulated in mela-
noma cells and metastatic melanomas 
(de Wit et al., 2005).
Similar to TGF-β, MIC-1 might acti-
vate Smad, but the signaling pathway 
downstream from MIC-1 remains 
poorly understood. In breast and gas-
tric cancer cell lines expressing acti-
vated ErbB2 and high levels of ERK1/2 
and Akt, MIC-1 quickly induced 
phosphorylation of ERK1/2 and Akt, 
and a specific inhibitor of ErbB2 
completely abolished MIC-1-mediated 
phosphorylation (Kim et al., 2008). 
It is thus likely that MIC-1 mediates 
survival, growth, and progression of 
melanoma cells through MAPK–ERK 
and/or PI3-K–Akt pathways. It is also 
possible that excreted MIC-1 affects 
in vivo growth and invasive activities 
of melanoma cells through ERK- or 
Akt-mediated expression of vascular 
endothelial growth factor and matrix 
metalloproteinases. Further studies 
of signaling pathways upstream and 
downstream of MIC-1 are required 
for the elucidation of its biological 
roles in melanoma development and 
for prospective targeted therapy of 
melanoma.
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The Primary cilium:  
A Small Yet Mighty Organelle
Mindy C. DeRouen1 and Anthony E. Oro1
Primary cilia are small, cylindrical membrane protrusions on most vertebrate cell 
types. Despite an unassuming appearance, this organelle has proven to be a veri-
table nexus of tightly regulated cell-signal reception between the epithelium and 
mesenchyme. In this issue, Lehman et al. describe the necessity of Ift88 and intra-
flagellar transport for signal reception of the sonic hedgehog pathway in the dermal 
papilla of developing hair follicles.
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The vertebrate hair follicle has been a 
model of how organs throughout the 
body develop, regenerate, and, upon 
injury, repair themselves. As new tools 
are employed to investigate hair devel-
opment, surprising discoveries are being 
made with regard to the mechanisms 
used to precisely control tissue mor-
phogenesis. Studies over the past two 
decades have established the epithe-
lial placode, a region of crowded, mul-
tipotent epidermal keratinocytes, as the 
morphological onset of hair follicle (HF) 
development (Figure 1). Initiation of the 
placode requires signaling interactions 
between epithelial cells and adjacent 
dermal cells that will eventually form the 
specialized mesenchyme called the der-
mal papilla (DP). Following placode for-
mation, the nascent HF elongates to form 
the hair germ and the full-length hair fol-
licle. Elongation, as well as postnatal hair 
cycling, is directed by continued signal-
ing interactions between the two tissue 
compartments (Fuchs et al., 2001; Millar, 
2002).
Molecular analyses have identified 
most of the key morphogens compris-
ing the network of signals between the 
epithelium and the mesenchyme. These 
include Wnt, bone morphogenetic pro-
tein, and Notch/Delta pathways that 
define the early placode, in addition 
to sonic hedgehog (Shh) and platelet-
derived growth factor (PDGF) pathways 
that mediate the expansion of commit-
ted hair progenitor cells (Millar, 2002). In 
particular, the Shh ligand is expressed by 
the HF epithelium and received by both 
the epithelium and the mesenchyme, as 
evidenced by the expression of Shh tar-
get genes in both tissue compartments. 
This activity is required for elongation 
of the hair germ because hair follicles 
of Shh–/– mice do not progress past this 
stage. Furthermore, Shh signaling coop-
erates with PDGF signaling for proper DP 
maturation because both Shh and PDGF 
mutants have abnormal DP (Karlsson et 
al., 1999; St-Jacques et al., 1998). These 
studies highlight the importance of com-
binatorial signal transduction between 
tissue compartments and raise the ques-
tion of how these complex interactions 
are regulated in the skin.
Although the identity and interactions 
of these morphogens are now well estab-
lished, the spatial and temporal manner 
in which their signals are received has 
long been a mystery. This is particularly 
important given the impossibly small con-
centration of these morphogens and their 
receptors in the tissue and the powerful 
effects they have on the subsets of cells 
to which they signal. Recent genetic and 
cell biological studies suggest that the pri-
mary cilium (PC) is an essential point of 
regulation (Gao et al., 2008). The PC is a 
small (1–2 µm) microtubule-based organ-
elle that extends from the basal body into 
the extracellular space. It determines the 
localization of signaling molecules within 
its confines through intraflagellar trans-
port (IFT) along its microtubule skeleton. 
In this way, the PC regulates the activity 
of intracellular signaling components by 
determining their interactions with extra-
cellular ligands and processing machinery. 
In effect, this small organelle amplifies the 
ability of morphogens to affect receiving 
cells (Christensen et al., 2007).
Genetic studies indicate that the pri-
mary cilium plays a central role in verte-
brate Shh signaling. The hedgehog recep-
tor patched and the membrane-bound 
smoothened and the Gli transcription 
factors all localize to the PC. Mutations 
in ciliary components, which often result 
in Shh-relevant phenotypes, highlight the 
requirement of this structure for Shh sig-
naling in developmental contexts. Mouse 
mutants of both anterograde IFT compo-
nents, such as IFT88, and retrograde IFT 
components phenocopy Shh mutants 
of the neural tube and developing limb 
(Huangfu and Anderson, 2006; Michaud 
and Yoder, 2006). In this issue, Lehman 
et al. (2009) demonstrate the necessity of 
Ift88 in dermal cells for proper HF mor-
phogenesis and Shh signaling in hair fol-
licles of mice. These authors show that 
Ift88tm1Bky mice crossed to Prx1-cre mice, 
a line that specifically expresses Cre in 
the ventral dermis of murine skin, contain 
ventral dermal cells and, consequently, 
nascent DP, void of primary cilia. This 
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|The primary cilium is essential in the regulation of 
hair development.
